Bellevue Biotech DT CHF
WKN A1H8PS | ISIN CH0113817123 | Fonds
Fonds
ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
---|---|---|---|---|---|---|
1 | LU2441282626 | Janus Henderson Horizon Biotechnology Fund IU2 EUR | +19,16 % | +20,77 % | 0,79 |
|
2 | IE00B3WVRB16 | Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares | +18,71 % | +20,63 % | 0,77 |
|
3 | LU2441282899 | Janus Henderson Horizon Biotechnology Fund A2 EUR | +18,84 % | +20,99 % | 0,76 |
|
4 | LU1269736838 | Candriam Equities L Biotech.R EUR Acc | +13,47 % | +18,21 % | 0,58 |
|
5 | LU1120766032 | Candriam Equities L Biotech.I EUR Acc | +12,57 % | +18,04 % | 0,54 |
|
24 | CH0113817123 | Bellevue Biotech DT CHF | +8,87 % | +18,88 % | 0,32 |
|
72 | LU1176839154 | Protea Fund - Sectoral Biotech Opportunities Fund IF USD | -1,08 % | +17,07 % | -0,23 |
|
73 | LU2208649280 | UBS(Lux)E.F.-Biotech(USD)QL a.USD | -2,00 % | +20,17 % | -0,24 |
|
74 | LU0400035332 | UBS(Lux)E.F.-Biotech(USD)Q a.USD | -2,20 % | +20,17 % | -0,25 |
|
75 | LU1176840327 | Protea Fund - Sectoral Biotech Opportunities Fund PF USD | -1,88 % | +17,15 % | -0,28 |
|
76 | LU0069152568 | UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD | -3,19 % | +20,17 % | -0,30 |
|